Variant · Snv
NT5C3A NM_001002010.5(NT5C3A):c.440+9A>G
CI-VAR-00134847Explore in graph →NM_001002010.5:c.440+9A>GClinVar 811542 rs72555745
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 811542 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency; Uterine corpus endometrial carcinoma; Clear cell carcinoma of kidney; Uveal melanoma; Cholangiocarcinoma; Acute myeloid leukemia; Malignant tumor of esophagus; Cervical cancer; Sarcoma; Malignant lymphoma, large B-cell, diffuse; Ovarian serous cystadenocarcinoma; Gastric cancer | germline | 4 | Jan 27, 2026 | clinvar |